Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Modeling Myeloma Dissemination In Vitro with hMSC-interacting Subpopulations of INA-6 Cells and Their Aggregation/Detachment Dynamics.
Kuric M, Beck S, Schneider D, Rindt W, Evers M, Meißner-Weigl J, Zeck S, Krug M, Herrmann M, Hartmann TN, Leich E, Rudert M, Docheva D, Seckinger A, Hose D, Jundt F, Ebert R. Kuric M, et al. Among authors: hartmann tn. Cancer Res Commun. 2024 Apr 29;4(4):1150-1164. doi: 10.1158/2767-9764.CRC-23-0411. Cancer Res Commun. 2024. PMID: 38598843 Free PMC article.
Modifying akt signaling in B-cell chronic lymphocytic leukemia cells.
Hofbauer SW, Piñón JD, Brachtl G, Haginger L, Wang W, Jöhrer K, Tinhofer I, Hartmann TN, Greil R. Hofbauer SW, et al. Among authors: hartmann tn. Cancer Res. 2010 Sep 15;70(18):7336-44. doi: 10.1158/0008-5472.CAN-09-4411. Epub 2010 Sep 7. Cancer Res. 2010. PMID: 20823161
CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression.
Tissino E, Pozzo F, Benedetti D, Caldana C, Bittolo T, Rossi FM, Bomben R, Nanni P, Chivilò H, Cattarossi I, Zaina E, Norris K, Polesel J, Gentile M, Tripepi G, Moia R, Santinelli E, Innocenti I, Olivieri J, D'Arena G, Laurenti L, Zaja F, Pozzato G, Chiarenza A, Di Raimondo F, Rossi D, Pepper C, Hartmann TN, Gaidano G, Del Poeta G, Gattei V, Zucchetto A. Tissino E, et al. Among authors: hartmann tn. Blood. 2020 Apr 9;135(15):1244-1254. doi: 10.1182/blood.2019003179. Blood. 2020. PMID: 32006000 Free PMC article.
Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myeloma.
Keppler-Hafkemeyer A, Greil C, Wratil PR, Shoumariyeh K, Stern M, Hafkemeyer A, Ashok D, Hollaus A, Lupoli G, Priller A, Bischof ML, Ihorst G, Engelhardt M, Marks R, Finke J, Bertrand H, Dächert C, Muenchhoff M, Badell I, Emmerich F, Halder H, Spaeth PM, Knolle PA, Protzer U, von Bergwelt-Baildon M, Duyster J, Hartmann TN, Moosmann A, Keppler OT. Keppler-Hafkemeyer A, et al. Among authors: hartmann tn. Nat Cancer. 2023 Jan;4(1):81-95. doi: 10.1038/s43018-022-00502-x. Epub 2022 Dec 21. Nat Cancer. 2023. PMID: 36543907 Free PMC article.
Development of combination therapies with BTK inhibitors and dasatinib to treat CNS-infiltrating E2A-PBX1+/preBCR+ ALL.
Gentile G, Poggio T, Catalano A, Voutilainen M, Lahnalampi M, Andrade-Martinez M, Ma T, Sankowski R, Goncharenko L, Tholen S, Han K, Morgens DW, Prinz M, Lübbert M, Engel S, Hartmann TN, Cario G, Schrappe M, Lenk L, Stanulla M, Duyster J, Bronsert P, Bassik MC, Cleary ML, Schilling O, Heinäniemi M, Duque-Afonso J. Gentile G, et al. Among authors: hartmann tn. Blood Adv. 2024 Jun 11;8(11):2846-2860. doi: 10.1182/bloodadvances.2023011582. Blood Adv. 2024. PMID: 38598725 Free PMC article.
Rac GTPases in Hematological Malignancies.
Durand-Onaylı V, Haslauer T, Härzschel A, Hartmann TN. Durand-Onaylı V, et al. Among authors: hartmann tn. Int J Mol Sci. 2018 Dec 14;19(12):4041. doi: 10.3390/ijms19124041. Int J Mol Sci. 2018. PMID: 30558116 Free PMC article. Review.
84 results